Incorporating systems-level stakeholder perspectives into the clinical trial design of school-supervised asthma therapy
dc.contributor.advisor | Michelle Trivedi, MD, MPH | |
dc.contributor.author | Trivedi, Michelle | |
dc.contributor.author | Hoque, Shushmita | |
dc.contributor.author | Luther, Janki | |
dc.contributor.author | Spano, Michelle | |
dc.contributor.author | Shillan, Holly | |
dc.contributor.author | Pearl, Hallie | |
dc.contributor.author | Seay, Hannah L. | |
dc.contributor.author | Phipatanakul, Wanda | |
dc.contributor.author | Gerald, Lynn B. | |
dc.contributor.author | Pbert, Lori | |
dc.date | 2022-08-11T08:10:56.000 | |
dc.date.accessioned | 2022-08-23T17:25:15Z | |
dc.date.available | 2022-08-23T17:25:15Z | |
dc.date.issued | 2021-09-01 | |
dc.date.submitted | 2021-09-21 | |
dc.identifier.citation | <p>Trivedi M, Hoque S, Luther J, Spano M, Shillan H, Pearl H, Seay H, Phipatanakul W, Gerald LB, Pbert L. Incorporating systems-level stakeholder perspectives into the clinical trial design of school-supervised asthma therapy. Contemp Clin Trials. 2021 Sep;108:106510. doi: 10.1016/j.cct.2021.106510. Epub 2021 Jul 16. PMID: 34280575; PMCID: PMC8453113. <a href="https://doi.org/10.1016/j.cct.2021.106510">Link to article on publisher's site</a></p> | |
dc.identifier.issn | 1551-7144 (Linking) | |
dc.identifier.doi | 10.1016/j.cct.2021.106510 | |
dc.identifier.pmid | 34280575 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/49366 | |
dc.description | <p>Shushmita Hoque participated in this study as a medical student in the Senior Scholars research program at the University of Massachusetts Medical School.</p> | |
dc.description.abstract | RATIONALE: Few evidence-based public health interventions are adopted in practice, in part due to a disconnect between the outcomes measured in clinical trials and the outcomes important to stakeholders that determine implementation in real-world practice. AsthmaLink is a school-supervised asthma therapy program which partners pediatric providers, school nurses, and families. To inform the design of a cluster randomized controlled trial of AsthmaLink, we elicited systems-level stakeholder input. METHODS: Maximum variation sampling was used to recruit 18 stakeholders to participate in semi-structured interviews that were recorded, transcribed, and open coded: Department of Public Health officials (n = 4), school officials (n = 4), pediatric practice managers (n = 3), health insurance officials (n = 4), and legislators (n = 3). Thematic analysis was used to identify common themes related to stakeholder priorities for clinical trial design and perceived barriers to AsthmaLink adoption. RESULTS: Stakeholder groups identified common priorities for the clinical trial design, including examination of the extent to which AsthmaLink (1) reduces health care utilization, (2) is cost effective (2) addresses health disparities, (3) reduces school absenteeism, and (4) educates families about asthma. Stakeholder groups reported potential barriers to AsthmaLink adoption, including challenges pertaining to (1) securing resources, staffing, and reimbursement, (2) variability across school districts, and (3) standing out amidst multiple programs vying for resources. CONCLUSIONS: Systems-level stakeholder input informed refinements to the clinical trial design of a school-supervised therapy program including outcome and implementation measures and choice of study population. Incorporating systems-level stakeholder perspectives into clinical trial design is critical to achieve adoption of evidence-based interventions into practice. | |
dc.language.iso | en_US | |
dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=34280575&dopt=Abstract">Link to Article in PubMed</a></p> | |
dc.relation.url | https://doi.org/10.1016/j.cct.2021.106510 | |
dc.subject | Childhood asthma | |
dc.subject | Clinical trial design | |
dc.subject | Implementation | |
dc.subject | Stakeholder engagement | |
dc.subject | UMCCTS funding | |
dc.subject | Clinical Trials | |
dc.subject | Community-Based Research | |
dc.subject | Medical Education | |
dc.subject | Pediatrics | |
dc.subject | Public Health | |
dc.subject | Pulmonology | |
dc.subject | Respiratory Tract Diseases | |
dc.title | Incorporating systems-level stakeholder perspectives into the clinical trial design of school-supervised asthma therapy | |
dc.type | Journal Article | |
dc.source.journaltitle | Contemporary clinical trials | |
dc.source.volume | 108 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/ssp/305 | |
dc.identifier.contextkey | 25048481 | |
html.description.abstract | <p>RATIONALE: Few evidence-based public health interventions are adopted in practice, in part due to a disconnect between the outcomes measured in clinical trials and the outcomes important to stakeholders that determine implementation in real-world practice. AsthmaLink is a school-supervised asthma therapy program which partners pediatric providers, school nurses, and families. To inform the design of a cluster randomized controlled trial of AsthmaLink, we elicited systems-level stakeholder input.</p> <p>METHODS: Maximum variation sampling was used to recruit 18 stakeholders to participate in semi-structured interviews that were recorded, transcribed, and open coded: Department of Public Health officials (n = 4), school officials (n = 4), pediatric practice managers (n = 3), health insurance officials (n = 4), and legislators (n = 3). Thematic analysis was used to identify common themes related to stakeholder priorities for clinical trial design and perceived barriers to AsthmaLink adoption.</p> <p>RESULTS: Stakeholder groups identified common priorities for the clinical trial design, including examination of the extent to which AsthmaLink (1) reduces health care utilization, (2) is cost effective (2) addresses health disparities, (3) reduces school absenteeism, and (4) educates families about asthma. Stakeholder groups reported potential barriers to AsthmaLink adoption, including challenges pertaining to (1) securing resources, staffing, and reimbursement, (2) variability across school districts, and (3) standing out amidst multiple programs vying for resources.</p> <p>CONCLUSIONS: Systems-level stakeholder input informed refinements to the clinical trial design of a school-supervised therapy program including outcome and implementation measures and choice of study population. Incorporating systems-level stakeholder perspectives into clinical trial design is critical to achieve adoption of evidence-based interventions into practice.</p> | |
dc.identifier.submissionpath | ssp/305 | |
dc.contributor.department | Prevention Research Center | |
dc.contributor.department | Senior Scholars Program | |
dc.contributor.department | School of Medicine | |
dc.contributor.department | Department of Population and Quantitative Health Sciences | |
dc.contributor.department | Division of Pulmonary Medicine, Department of Pediatrics | |
dc.source.pages | 106510 |
Files in this item
This item appears in the following Collection(s)
-
T.H. Chan School of Medicine Student Publications [500]
-
Senior Scholars Program [329]
-
UMass Center for Clinical and Translational Science Supported Publications [855]
-
Prevention Research Center Publications [317]
-
UMass Chan Faculty and Researcher Publications [14819]
-
Population and Quantitative Health Sciences Publications [2203]